Banjai Mochahary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Banjai Mochahary has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Arvind Kumar Goyal
Bamboo Technology, Department of Biotechnology, Bodoland University, Kokrajhar 783370, Assam, India
4 shared publications - Mrinal Kalita
Department of Biotechnology, Bodoland University, Kokajhar-783 370, Assam, India
2 shared publications - Sudem Brahma
Department of Biotechnology, Bodoland University, Kokrajhar-783370, BTR, Assam, India
2 shared publications - Sushil Kumar Middha
DBT-BIF Facility, Department of Biotechnology, Maharani Lakshmi Ammanni College for Women, 560012 Bangalore, India
2 shared publications - Talambedu Usha
Department of Biochemistry, Bangalore University, Bengaluru, Karnataka, India
2 shared publications A Swranakar
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Horizon E-Publishing Group in Plant Science Today
Hepatoprotective activities of polyherbal formulations: Current evidence and future perspectives
Medicinal plants have long been used in the management of diverse diseases worldwide. In recent years, increasing attention has been directed toward the scientific evaluation of polyherbal formulations (PHFs) to integrate traditional knowledge with modern pharmacological principles and ensure safety and efficacy, particularly in liver disorders. This review summarises PHFs with hepatoprotective activity reported over the past decade, based on literature retrieved from MEDLINE, PubMed and Google Scholar. A total of 93 PHFs were identified, which utilised 166 plant species from 73 botanical families. The family Fabaceae was the most represented, with 14 species used in various formulations. Among the most frequently utilised ingredients were Picrorhiza kurroa Royle ex Benth. (aerial parts; 26 formulations), Cichorium intybus L. (seeds and root bark; 24 formulations) and Andrographis paniculata (Burm.f.) Wall. ex Nees (leaves; 23 formulations). Interestingly, several marketed PHFs also included non-herbal components such as olive oil, honey, bhasmas (calcined minerals) and cow ghee. Preclinical and clinical investigations have consistently demonstrated the hepatoprotective potential of these formulations against diverse models of liver injury. India accounts for the highest number of commercially available PHFs, followed by South Korea, Nigeria, Pakistan and Saudi Arabia, while countries such as Bangladesh, Iran, Sri Lanka, China and Taiwan predominantly utilise traditional herbal preparations. Despite their growing global acceptance, many classical PHFs lack rigorous scientific validation. Standardisation of composition, elucidation of the mechanisms of action and well-designed clinical trials are essential to validate the pharmacological effects of herbal ingredients and substantiate the therapeutic roles of PHFs in preventing and managing liver diseases.
- 10 November 2026
- Published by Horizon E-Publishing Group in Plant Science Today
Open AccessHepatoprotective activities of polyherbal formulations: Current evidence and future perspectives
Medicinal plants have long been used in the management of diverse diseases worldwide. In recent years, increasing attention has been directed toward the scientific evaluation of polyherbal formulations (PHFs) to integrate traditional knowledge with modern pharmacological principles and ensure safety and efficacy, particularly in liver disorders. This review summarises PHFs with hepatoprotective activity reported over the past decade, based on literature retrieved from MEDLINE, PubMed and Google Scholar. A total of 93 PHFs were identified, which utilised 166 plant species from 73 botanical families. The family Fabaceae was the most represented, with 14 species used in various formulations. Among the most frequently utilised ingredients were Picrorhiza kurroa Royle ex Benth. (aerial parts; 26 formulations), Cichorium intybus L. (seeds and root bark; 24 formulations) and Andrographis paniculata (Burm.f.) Wall. ex Nees (leaves; 23 formulations). Interestingly, several marketed PHFs also included non-herbal components such as olive oil, honey, bhasmas (calcined minerals) and cow ghee. Preclinical and clinical investigations have consistently demonstrated the hepatoprotective potential of these formulations against diverse models of liver injury. India accounts for the highest number of commercially available PHFs, followed by South Korea, Nigeria, Pakistan and Saudi Arabia, while countries such as Bangladesh, Iran, Sri Lanka, China and Taiwan predominantly utilise traditional herbal preparations. Despite their growing global acceptance, many classical PHFs lack rigorous scientific validation. Standardisation of composition, elucidation of the mechanisms of action and well-designed clinical trials are essential to validate the pharmacological effects of herbal ingredients and substantiate the therapeutic roles of PHFs in preventing and managing liver diseases.
- Open Access
- 1 October 2023
- Published by Horizon E-Publishing Group in Plant Science Today
Evaluating hepatoprotective activity of polyherbal formulations- an overview of dietary antioxidants
Chronic liver disease is the foremost cause of morbidity, accounting for 2.2 percent of death. In recent years, excessive attention has been focused on using natural antioxidants as they have the potential to minimize oxidative stress in cells and thus help treat various ailments. Some scientists estimate that two-thirds of plant species have medical applications, and many of these have significant antioxidant potential. Polyherbal formulations (PHFs) have shown therapeutic promise in the treatment of several acute and chronic conditions, including diabetes, wound care, hypertension, cardiovascular disorders, anxiety, neurological imbalances, and disorders of the gastrointestinal, respiratory, and endocrine systems. This article reviews the antioxidant potential of the various polyherbal formulations developed to treat hepatic disorders during the past ten years. After preliminary screening, 53 abstracts based on the polyherbal formulations selected for hepatoprotection were retrieved from several bibliographical databases. This review provides insight and indicates the gaps presented in the case of polyherbal formulations (PHFs) formulations. To conclude, PHFs can activate several physiological processes that quicken the process. Clinical trials should be conducted to further examine these PHFs, and production upscaling will help to open up new markets for PHFs.
- 1 October 2023
- Published by Horizon E-Publishing Group in Plant Science Today
Open AccessEvaluating hepatoprotective activity of polyherbal formulations- an overview of dietary antioxidants
Chronic liver disease is the foremost cause of morbidity, accounting for 2.2 percent of death. In recent years, excessive attention has been focused on using natural antioxidants as they have the potential to minimize oxidative stress in cells and thus help treat various ailments. Some scientists estimate that two-thirds of plant species have medical applications, and many of these have significant antioxidant potential. Polyherbal formulations (PHFs) have shown therapeutic promise in the treatment of several acute and chronic conditions, including diabetes, wound care, hypertension, cardiovascular disorders, anxiety, neurological imbalances, and disorders of the gastrointestinal, respiratory, and endocrine systems. This article reviews the antioxidant potential of the various polyherbal formulations developed to treat hepatic disorders during the past ten years. After preliminary screening, 53 abstracts based on the polyherbal formulations selected for hepatoprotection were retrieved from several bibliographical databases. This review provides insight and indicates the gaps presented in the case of polyherbal formulations (PHFs) formulations. To conclude, PHFs can activate several physiological processes that quicken the process. Clinical trials should be conducted to further examine these PHFs, and production upscaling will help to open up new markets for PHFs.
- Open Access
- 9 May 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (sp2) , 1-7
Pharmacognostic and physicochemical characterisation of potential plants for antidiabetic herbal formulations
In recent years, mankind has relied largely on herbal medicines to treat a variety of ailments. The aim of the current study is to investigate the pharmacognostic and physicochemical characterisation of some medicinal plants such as Bambusa balcooa (leaf) (BBL), Phyllanthus emblica (fruit) (PEF), Hodgsonia heteroclita (fruit pulp) (HHP), and Punica granatum (fruit peel) (PGP) used by the local Bodo tribe for the treatment of diabetes, which can be combined together to develop a novel polyherbal formulation. The preliminary phytochemical screening, microscopic evaluation, organoleptic and flow properties and qualitative heavy metal estimation was carried out usimng standard protocols. The preliminary phytochemical screening revealed the existence of carbohydrates, phenolics, alkaloids in all. However, amino acids were present in P. granatum and P. emblica, whereas triterpenoids were inferred in P. officinalis. Microscopical analysis of crude showed the presence of stone cells (BBL, HHP and PGP), xylem (PEF, HHP and PGP), trichome (PGP), fibres (all) and epidermis (PEF). The macroscopical study of crushed powder was overall acceptable to sense organs. The physical evaluation of flow properties was found to be good for P. emblica fruit when compared to others which was fair to passable. The heavy metal test showed the absence of bismuth, cadmium and lead in all species. Accordingly, the results obtained from the study is endowed with essential information for the authentication and quality assessment of these herbal drugs.
- 9 May 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (sp2) , 1-7
Open AccessPharmacognostic and physicochemical characterisation of potential plants for antidiabetic herbal formulations
In recent years, mankind has relied largely on herbal medicines to treat a variety of ailments. The aim of the current study is to investigate the pharmacognostic and physicochemical characterisation of some medicinal plants such as Bambusa balcooa (leaf) (BBL), Phyllanthus emblica (fruit) (PEF), Hodgsonia heteroclita (fruit pulp) (HHP), and Punica granatum (fruit peel) (PGP) used by the local Bodo tribe for the treatment of diabetes, which can be combined together to develop a novel polyherbal formulation. The preliminary phytochemical screening, microscopic evaluation, organoleptic and flow properties and qualitative heavy metal estimation was carried out usimng standard protocols. The preliminary phytochemical screening revealed the existence of carbohydrates, phenolics, alkaloids in all. However, amino acids were present in P. granatum and P. emblica, whereas triterpenoids were inferred in P. officinalis. Microscopical analysis of crude showed the presence of stone cells (BBL, HHP and PGP), xylem (PEF, HHP and PGP), trichome (PGP), fibres (all) and epidermis (PEF). The macroscopical study of crushed powder was overall acceptable to sense organs. The physical evaluation of flow properties was found to be good for P. emblica fruit when compared to others which was fair to passable. The heavy metal test showed the absence of bismuth, cadmium and lead in all species. Accordingly, the results obtained from the study is endowed with essential information for the authentication and quality assessment of these herbal drugs.
- Open Access
- 9 May 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (sp2) , 8-17
Characterisation of indigenous plants for herbal formulations preparation based on pharmacognostic and physiochemical data
The use of plant-based drugs has increased considerably in the modern world for their efficiency in managing diseases with lesser side effects than synthetic drugs. The current study was aimed to confirm the identity, quality and purity of some locally available potential medicinal plants such as Alstonia scholaris (bark), Centella asiatica (whole plant), Drymaria cordata (whole plant), Hydrocotyle sibthorpioides (whole plant), Oroxylum indicum (bark), Senna hirsuta (leaf), Senna occidentalis (leaf), Solanum indicum (root), Stephania japonica (tuber) in powdered form. The powdered plant parts were evaluated for preliminary phytochemicals, pharmacognostical studies, physical characteristics and heavy metals. Preliminary phytochemical screening of the different extracts inferred the existence of carbohydrates, phenolics, alkaloids and amino acids while triterpenoids were absent. Microscopical study of the powder revealed the diagnostic qualities such as stone cells, trichomes, stomata, calcium oxalate crystal, fibres, xylem vessel, pitted spiral vessels, etc. The colour, odour, flavour/taste and texture of the pulverized plant were overall acceptable. The physical characteristics which determine the flow rate of the powder with respect to Carr’s index and Hausner’s ratio were found to be good to passable except for Hydrocotyle sibthorpioides (whole plant), Oroxylum indicum (bark), which were not easily passable. The heavy metal test showed the absence of bismuth, cadmium and lead. Thus the present study may serve as a standard reference for the quality control analysis of the herbal drug either singly or in synergy.
- 9 May 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (sp2) , 8-17
Open AccessCharacterisation of indigenous plants for herbal formulations preparation based on pharmacognostic and physiochemical data
The use of plant-based drugs has increased considerably in the modern world for their efficiency in managing diseases with lesser side effects than synthetic drugs. The current study was aimed to confirm the identity, quality and purity of some locally available potential medicinal plants such as Alstonia scholaris (bark), Centella asiatica (whole plant), Drymaria cordata (whole plant), Hydrocotyle sibthorpioides (whole plant), Oroxylum indicum (bark), Senna hirsuta (leaf), Senna occidentalis (leaf), Solanum indicum (root), Stephania japonica (tuber) in powdered form. The powdered plant parts were evaluated for preliminary phytochemicals, pharmacognostical studies, physical characteristics and heavy metals. Preliminary phytochemical screening of the different extracts inferred the existence of carbohydrates, phenolics, alkaloids and amino acids while triterpenoids were absent. Microscopical study of the powder revealed the diagnostic qualities such as stone cells, trichomes, stomata, calcium oxalate crystal, fibres, xylem vessel, pitted spiral vessels, etc. The colour, odour, flavour/taste and texture of the pulverized plant were overall acceptable. The physical characteristics which determine the flow rate of the powder with respect to Carr’s index and Hausner’s ratio were found to be good to passable except for Hydrocotyle sibthorpioides (whole plant), Oroxylum indicum (bark), which were not easily passable. The heavy metal test showed the absence of bismuth, cadmium and lead. Thus the present study may serve as a standard reference for the quality control analysis of the herbal drug either singly or in synergy.